Tremfya® Receives Approval for Treating Moderate to Severe Ulcerative Colitis with Subcutaneous Injection Tremfya® has been approved for treating moderate to severe ulcerative colitis through subcutaneous injection, marking a significant advancement in patient care.

Tremfya® Receives Approval for Treating Moderate to Severe Ulcerative Colitis with Subcutaneous Injection #Japan #TREMFYA® #Tokyo #Janssen #UC_treatment